Grufity logo
Grufity logo

Latest SUVRETTA CAPITAL MANAGEMENT, LLC Stock Portfolio

$3.92Billion– No. of Holdings #88

SUVRETTA CAPITAL MANAGEMENT, LLC Performance:
2026 Q1: -3.72%YTD: -3.72%2025: 22.41%
Performance for 2026 Q1 is -3.72%, and YTD is -3.72%, and 2025 is 22.41%.

About SUVRETTA CAPITAL MANAGEMENT, LLC and 13F Hedge Fund Stock Holdings

SUVRETTA CAPITAL MANAGEMENT, LLC is a hedge fund based in New York, NY. On 2026-05-15, the fund reported it's updated stock portfolio. In the 13F Holdings report, SUVRETTA CAPITAL MANAGEMENT, LLC reported an equity portfolio of $3.9 Billions as of 31 Mar, 2026.

The top stock holdings of SUVRETTA CAPITAL MANAGEMENT, LLC are ARQT, , . The fund has invested 7.4% of it's portfolio in ARCUTIS BIOTHERAPEUTICS INC and 6.7% of portfolio in VERADERMICS INC.

The fund managers got completely rid off COCA COLA CO (KO), SERVICENOW INC (NOW) and SALESFORCE INC (CRM) stocks. They significantly reduced their stock positions in MICROSOFT CORP (MSFT), TESLA INC (TSLA) and DANAHER CORP DEL (DHR). SUVRETTA CAPITAL MANAGEMENT, LLC opened new stock positions in VERADERMICS INC, VULCAN MATLS CO (VMC) and CRINETICS PHARMACEUTICALS IN (CRNX). The fund showed a lot of confidence in some stocks as they added substantially to REPLIMUNE GROUP INC (REPL), MEDTRONIC PLC (MDT) and INTUITIVE SURGICAL INC (ISRG).
SUVRETTA CAPITAL MANAGEMENT, LLC Equity Portfolio Value
Last Reported on: 15 May, 2026

SUVRETTA CAPITAL MANAGEMENT, LLC Annual Return Estimates Vs S&P 500

Our best estimate is that SUVRETTA CAPITAL MANAGEMENT, LLC made a return of -3.72% in the last quarter. In trailing 12 months, it's portfolio return was 28.72%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
veradermics inc263,270,000
vulcan matls co49,448,000
crinetics pharmaceuticals in37,913,700
us foods hldg corp36,512,400
performance food group co33,140,600
life time group holdings inc13,748,800
wingstop inc9,220,720
anteris technologies global4,717,500
New stocks bought by SUVRETTA CAPITAL MANAGEMENT, LLC

Additions

Ticker% Inc.
replimune group inc11,615
medtronic plc188
intuitive surgical inc117
capricor therapeutics inc113
mgm resorts international79.59
capital one finl corp75.84
edwards lifesciences corp68.47
zura bio ltd62.87
Additions to existing portfolio by SUVRETTA CAPITAL MANAGEMENT, LLC

Reductions

Ticker% Reduced
microsoft corp-96.89
tesla inc-94.33
danaher corp del-85.11
coherent corp-78.25
erasca inc-76.31
johnson & johnson-76.31
boston scientific corp-64.94
amazon com inc-37.46
SUVRETTA CAPITAL MANAGEMENT, LLC reduced stake in above stock

Sold off

Ticker$ Sold
rocket pharmaceuticals inc-10,504,500
tango therapeutics inc-23,587,300
ultragenyx pharmaceutical in-46,437,000
coca cola co-96,668,100
uniqure nv-29,116,400
chipotle mexican grill inc-25,393,100
servicenow inc-59,659,100
oracle corp-44,111,600
SUVRETTA CAPITAL MANAGEMENT, LLC got rid off the above stocks

Sector Distribution

SUVRETTA CAPITAL MANAGEMENT, LLC has about 41.4% of it's holdings in Healthcare sector.

  • Healthcare
  • Others
  • Consumer Cyclical
  • Technology
  • Consumer Defensive
  • Financial Services
  • Communication Services
  • Industrials
  • Basic Materials
Sector%
Healthcare41.4
Others34.2
Consumer Cyclical6.3
Technology4.4
Consumer Defensive4.1
Financial Services3.2
Communication Services2.6
Industrials2.4
Basic Materials1.3

Market Cap. Distribution

SUVRETTA CAPITAL MANAGEMENT, LLC has about 24.5% of it's portfolio invested in the large-cap and mega-cap stocks.

  • UNALLOCATED
  • SMALL-CAP
  • MID-CAP
  • MEGA-CAP
  • LARGE-CAP
Category%
UNALLOCATED34.1
SMALL-CAP20.9
MID-CAP20
MEGA-CAP15.6
LARGE-CAP8.9

Stocks belong to which Index?

About 52.1% of the stocks held by SUVRETTA CAPITAL MANAGEMENT, LLC either belong to S&P 500 or RUSSELL 2000 index.

  • Others
  • RUSSELL 2000
  • S&P 500
Index%
Others47.9
RUSSELL 200028.1
S&P 50024
Top 5 Winners (%)%
ERAS
erasca inc
207.1 %
APLS
apellis pharmaceuticals inc
55.6 %
AADI
whitehawk therapeutics inc
42.6 %
KALV
kalvista pharmaceuticals inc
24.6 %
AURA
aura biosciences inc
22.8 %
Top 5 Winners ($)$
ERAS
erasca inc
111.7 M
APLS
apellis pharmaceuticals inc
57.9 M
palvella therapeutics inc ne
20.4 M
KALV
kalvista pharmaceuticals inc
19.0 M
arrivent biopharma inc
12.5 M
Top 5 Losers (%)%
lexeo therapeutics inc
-42.2 %
VRDN
viridian therapeutics inc
-37.1 %
FULC
fulcrum therapeutics inc
-32.2 %
EYPT
eyepoint inc
-28.9 %
mineralys therapeutics inc
-25.4 %
Top 5 Losers ($)$
ARQT
arcutis biotherapeutics inc
-66.6 M
EYPT
eyepoint inc
-43.4 M
BNTC
benitec biopharma inc
-32.6 M
biohaven ltd
-29.1 M
LEGN
legend biotech corp
-25.9 M

SUVRETTA CAPITAL MANAGEMENT, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of SUVRETTA CAPITAL MANAGEMENT, LLC

SUVRETTA CAPITAL MANAGEMENT, LLC has 88 stocks in it's portfolio. About 39.4% of the portfolio is in top 10 stocks. ARQT proved to be the most loss making stock for the portfolio. ERAS was the most profitable stock for SUVRETTA CAPITAL MANAGEMENT, LLC last quarter.

Last Reported on: 15 May, 2026
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions